DocGo Inc. Foreign Currency Transaction Gain (Loss), Realized
DocGo Inc. (DCGO) reported Foreign Currency Transaction Gain (Loss), Realized of $924 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2023-11-06
- DocGo Inc. foreign currency transaction gain (loss), realized for the quarter ending 2023-09-30 was $924.00, a 18.92% increase year-over-year.
- DocGo Inc. foreign currency transaction gain (loss), realized for the quarter ending 2023-06-30 was $6.41K, a 459.83% increase year-over-year.
- DocGo Inc. foreign currency transaction gain (loss), realized for the quarter ending 2022-12-31 was $4.44T.
- DocGo Inc. foreign currency transaction gain (loss), realized for the quarter ending 2022-09-30 was $777.00.
- DocGo Inc. foreign currency transaction gain (loss), realized for fiscal 2022 was $4.44T, a 9684211919.38% increase from fiscal 2021.
- DocGo Inc. foreign currency transaction gain (loss), realized for fiscal 2021 was $45.83K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $924.00 10-Q · filed 2023-11-06 | $7.33K derived: sum of 2 quarters · filed 2023-11-06 | $6.70K 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | $6.41K 10-Q · filed 2023-08-08 | $5.77K 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $4.44T derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $4.44T derived: sum of 2 quarters · filed 2023-11-06 | $4.44T derived: sum of 3 quarters · filed 2023-11-06 | $4.44T 10-K · filed 2023-03-14 | |
| 2022-09-30 | $777.00 10-Q · filed 2023-11-06 | $1.92K derived: sum of 2 quarters · filed 2023-11-06 | -$18.88K 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $1.15K 10-Q · filed 2023-08-08 | $19.66K 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | -$281.95K 10-Q · filed 2023-05-09 | $20.80K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $45.83K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |